Camber-logo (Camber Logo)
Zileuton Tablet, Film Coated, Extended Release
Product Images NDC 31722-044
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zileuton (NDC 31722-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container-label (Container Label)
This is a medication package for Zileuton extended-release tablets. Each film-coated tablet has 600mg zileuton USP. The usual dosage information is available in the package insert, and it is recommended not to chew or crush the tablets. The tablets should be stored between 20°C to 25°C (68°F to 77°F) and protected from light, and it should be obtained in a USP tight, light-resistant container, without accepting it if the seal over the bottle opening is broken or missing. Dispensing with patient information is also recommended by the pharmacist.*
Zileutonertabfigure (Zileutonertabfigure)
Zileuton Extended-Release Tablets is a medication evaluated in a clinical study for weeks 0, 2, 4, 8, 12, and endpoint. The study consisted of 192 patients who were given Zileuton Extended-Release Tablets and 187 patients who were given a placebo. Throughout the study, the number of patients decreased in both groups.*
Zileutonertabstructure (Zileutonertabstructure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
